BioSpace News Archive

The earth has finally moved for doctors in Washington. The Union of American Physicians and Dentists (UAPD) demonstrated its power to affect positive change in its first two contract negotiations in Washington state.

A new procedure pioneered by Norton Healthcare physician-scientists directly targets brain tissue affected by radiation necrosis.

AIDS activists Gregg Gonsalves, Brenda Goodrow, Andrew Spieldenner, Peter Staley, Robert Vázquez, and Jason Walker joined with other consumers in filing an antitrust complaint in federal court in San Francisco against some of the nation’s largest pharmaceutical manufacturers, including Gilead Sciences, Inc., Bristol-Myers Squibb Company, and Johnson & Johnson, Inc.'s subsidiary Janssen R&D Ireland.

Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, today announced financial and operating results for the first quarter ended March 31, 2019 and provided a corporate update.

Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company developing next-generation neuromodulators for use in treating aesthetic and therapeutic conditions, today announced that the company will participate in the RBC Capital Markets 2019 Healthcare Conference in New York, NY.

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX:AUP) (“Aurinia” or the “Company”) today reported financial results for the first quarter ended March 31, 2019 and provided an update on recent operational highlights.

HG Awareness Day is an international event to increase awareness of the pregnancy disease called hyperemesis gravidarum (HG)

Neuralstem, Inc. (Nasdaq: CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell and small molecule compound technologies, reported its financial results for the first quarter ended March 31, 2019.

The 3M Board of Directors declared a dividend on the company’s common stock of $1.44 per share for the second quarter of 2019.

Nxt-ID, Inc., a provider of healthcare devices as well as payment, credential management, and authentication platform services, announces its next upcoming investor webcast.